期刊
JOURNAL OF INFECTIOUS DISEASES
卷 228, 期 -, 页码 S111-S116出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/infdis/jiad200
关键词
COVID-19; RNA; SARS-CoV-2; immunocompromise
Immunocompromised individuals with moderate/severe immunosuppression have higher nasal viral load and might have higher cumulative nasal RNA levels and plasma viremia. Immunosuppression leads to greater viral shedding and altered viral decay kinetics.
Immunocompromised individuals are disproportionately affected by severe coronavirus disease 2019, but immune compromise is heterogenous, and viral dynamics may vary by the degree of immunosuppression. In this study, we categorized ACTIV-2/A5401 participants based on the extent of immunocompromise into none, mild, moderate, and severe immunocompromise. Moderate/severe immunocompromise was associated with higher nasal viral load at enrollment (adjusted difference in means: 0.47 95% confidence interval, .12-.83 log10 copies/mL) and showed a trend toward higher cumulative nasal RNA levels and plasma viremia compared to nonimmunocompromised individuals. Immunosuppression leads to greater viral shedding and altered severe acute respiratory syndrome coronavirus 2 viral decay kinetics.Clinical Trials Registration. NCT04518410.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据